News Releases
| Date | Title | Format |
|---|---|---|
| January 19, 2021 | Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration | |
| January 6, 2021 | Histogen to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference | |
| January 5, 2021 | Histogen Announces Closing of $14.0 Million Upsized Public Offering |